NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/07/2023
Voltar para busca
Dado oficial do USPTO
SAMSUNG BIOLOGICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
SAMSUNG BIOLOGICS
ST13
US500000090380563Classe
1, 5, 40, 42
Pedido
90380563
Registro
7102687
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
26
Atualização mais recente
11/07/2023
Tipo de marca
Verbal
Classes Nice
1, 5, 40, 42
Data de depósito
14/12/2020
Data de registro
11/07/2023
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
11/07/2023
Última transação
11/07/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
03
Localização do titular
Seoul, KR
Examinador
MEIER, SHARON A
Unidade examinadora
M30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Samsung C&T Corporation
Representantes
Diane J. Mason FAEGRE DRINKER BIDDLE & REATH LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Enzymes derived from biotechnological processes for use in industry; cell growth media for growing cells for use in scientific research; stem cells for scientific purposes; cells for scientific or laboratory purposes; preparations for gene recombination for scientific or laboratory purposes; synthetic gene for research other than for medical purposes; chemicals for use in biotechnological product development; biological preparations for use in biotechnology other than for medical or veterinary use; biological tissue culturesother than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; probiotic bacterial cultures for the food industry; stem cells for research purposes; chemical reagents for use in genetic research; chemical reagents for genetic identity testing for non-medical purposes; stem cells other than for medical or veterinary purposes; chemical reagentsother than for medical or veterinary purpose; reagents for use in scientific apparatus for chemical or biological analysis
Classe 5
Bouillons for bacteriological cultures; biological reagents for veterinary purposes; biological tissue cultures for veterinary purposes; diagnostic test reagents for medical or veterinary purposes; in vitro diagnostic preparations for medical purposes; biological preparations for medical or veterinary purposes for the prevention and treatment of infectious diseases; reagents and media for medical and veterinary diagnostic purposes; cultures of microorganisms for medical or veterinary use; diagnostic preparations for medical and veterinary use; cultures for medical usebacteriological cultures for medical purposes; biological reagents for medical purposes; biological tissue cultures for medical purposes; stem cells for medical purposes; stem cells for medicalpharmaceutical or veterinary use; surgical implants grown from stem cells being living tissues; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for diagnosis for medical or veterinary purposes; radioisotope markers for therapeutic or diagnostic use
Classe 40
Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; Treatment of biopharmaceutical materialsprocessing finished products from raw biopharmaceutical materials; Production of cell lines for use in the manufacture of biopharmaceuticals; chemical treatment of liquids; processing of medicinal materialscustom manufacturing of pharmaceuticals; Custom manufacture of pharmaceuticals for others; processing of pharmaceutical preparations; preservation of pharmaceuticals; processing of medical products; processing of chemicals
Classe 42
Microbial culture trials; research and development of technology for biotechnology; crude medicines researchHerbal medicine research; biochemistry research services; bacteriological research and analysis; development of cell therapy products; development of pharmaceutical preparations and medicines; pharmaceutical products development; inspection of pharmaceuticals; research relating to pharmaceuticals; clinical testing of medicines; pharmaceutical products evaluation; scientific research in the field of genetic engineering; Genetic research for scientific purposes; medical laboratories; Medical research of medicines; research for medical products; Conducting clinical trials for others; stem cell research services
Publicações
Histórico de despachos e eventos da marca no USPTO.
26 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
11/07/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
25/04/2023
PUBO
PUBLISHED FOR OPPOSITION
25/04/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/04/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
21/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/03/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/03/2023
ALIE
ASSIGNED TO LIE
11/03/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
29/12/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
15/07/2022
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
11/07/2022
GNSI
INQUIRY TO SUSPENSION E-MAILED
11/07/2022
CNSI
SUSPENSION INQUIRY WRITTEN
11/07/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/01/2022
GNSL
LETTER OF SUSPENSION E-MAILED
03/01/2022
CNSL
SUSPENSION LETTER WRITTEN
03/01/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/12/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/12/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/12/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
18/06/2021
GNRT
NON-FINAL ACTION E-MAILED
18/06/2021
CNRT
NON-FINAL ACTION WRITTEN
18/06/2021
DOCK
ASSIGNED TO EXAMINER
05/06/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
22/02/2021
NWAP
NEW APPLICATION ENTERED
17/12/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SAMSUNG BIOLOGICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.